• Ocuphire Pharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 marketscreener.com Mon, 28 Apr 2025 12:50:56 GMT
• prism marketview spotlights opus genetics in new q&a with ceo george magrath Seeking Alpha Tue, 15 Apr 2025 14:36:00 GMT
• Opus Genetics (NASDAQ:IRD) Research Coverage Started at Craig Hallum Defense World Mon, 14 Apr 2025 07:00:00 GMT
• Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive ... The Manila Times Sat, 12 Apr 2025 07:00:00 GMT
• founder mina sooch issues open letter to opus genetics stockholders following withdrawal of the restore value slate amid dilutive ... The Manila Times Fri, 11 Apr 2025 19:58:40 GMT
• Drug company founder pulls plug on proxy fight at her former company Crain's Detroit Business Fri, 11 Apr 2025 07:00:00 GMT
• Night Vision Disturbances Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ocuphire Pharma, Viatris The Globe and Mail Thu, 10 Apr 2025 07:00:00 GMT
• opus genetics eyes 2026 start for pivotal trial of gene therapy for rare retinal disease Precision Medicine Online Thu, 10 Apr 2025 07:00:00 GMT
• opus genetics says mina sooch determined to withdraw her slate of nominees for election to board MarketScreener Wed, 09 Apr 2025 21:45:18 GMT
• mydriasis market predicted to see upsurge through 2034, highlights delveinsight | viatris/ocuphire pharma, eyenovia, rayner surgic... Barchart.com Wed, 09 Apr 2025 14:56:00 GMT
• opus genetics gets fda fast track designation for phentolamine ophthalmic solution MSN Wed, 09 Apr 2025 09:40:19 GMT
• Opus Genetics celebrates early win for retinal gene therapy in teen patient FirstWord Pharma Tue, 08 Apr 2025 07:00:00 GMT
• Opus Genetics' Future at Stake: Ex-CEO Challenges $21.5M-Backed Gene Therapy Transformation Stock Titan Mon, 07 Apr 2025 07:00:00 GMT
• Opus Genetics Files Definitive Proxy Statement and Sends GlobeNewswire Mon, 07 Apr 2025 07:00:00 GMT
• Opus Genetics (NASDAQ:IRD) Price Target Cut to $8.00 by Analysts at Jones Trading Defense World Wed, 02 Apr 2025 07:00:00 GMT
• opus genetics (nasdaq:ird) receives buy rating from hc wainwright Defense World Wed, 02 Apr 2025 07:00:00 GMT
• Ousted founder of drug development company tries to take back the reins Crain's Detroit Business Fri, 28 Mar 2025 07:00:00 GMT
• critical contrast: mersana therapeutics (nasdaq:mrsn) & opus genetics (nasdaq:ird) Defense World Fri, 28 Mar 2025 07:00:00 GMT
• opus genetics closes $20m offering, issues private placement by investing.com Investing.com India Tue, 25 Mar 2025 07:00:00 GMT
• Opus Genetics closes $20M offering, issues private placement Investing.com Mon, 24 Mar 2025 07:00:00 GMT
• Restore Value Slate Led by Mina Sooch Files Preliminary Proxy Materials for the Election of Six Highly Qualified Directors at the ... The Manila Times Sat, 22 Mar 2025 07:00:00 GMT
• opus genetics prices public offering, private placement -march 21, 2025 at 09:33 am edt MarketScreener Fri, 21 Mar 2025 13:39:52 GMT
• restore value slate led by mina sooch files preliminary proxy materials for the election of six highly qualified directors at the ... TradingView Fri, 21 Mar 2025 07:00:00 GMT
• opus genetics founder mina sooch files preliminary proxy materials for co board election MarketScreener Fri, 21 Mar 2025 07:00:00 GMT
• open angle glaucoma market to show remarkable growth trends from 2023 to 2032, delveinsight reports | visiox pharma, tearclear, vi... The Globe and Mail Fri, 21 Mar 2025 07:00:00 GMT
• Opus Genetics enhances shareholder rights, sues for patent infringement Investing.com Thu, 20 Mar 2025 07:00:00 GMT
• diabetic retinopathy clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Wed, 12 Mar 2025 17:48:00 GMT
• opus genetics in jan, got paragraph iv certification notice from winston & strawn, counsel to sandoz incorporated Marketscreener.com Tue, 04 Mar 2025 22:07:33 GMT
• opus genetics gets fda fast track designation for phentolamine ophthalmic solution MSN Thu, 27 Feb 2025 12:16:49 GMT
• opus genetics gets fda fast track designation for phentolamine ophthalmic solution MSN Wed, 26 Feb 2025 16:49:04 GMT
• shareholder group nominates slate of director candidates for opus genetics TipRanks Fri, 07 Feb 2025 14:52:48 GMT
• mina sooch nominates slate of director candidates to the board of opus genetics -february 07, 2025 at 09:15 am est Marketscreener.com Fri, 07 Feb 2025 14:15:00 GMT
• shareholder group led by founder mina sooch nominates majority slate of director candidates to the board of opus genetics, inc. TradingView Fri, 07 Feb 2025 08:00:00 GMT
• opus genetics revises executive compensation agreements Investing.com Fri, 24 Jan 2025 08:00:00 GMT
• opus genetics sets april 30 for 2025 annual meeting Investing.com India Fri, 24 Jan 2025 02:57:59 GMT
• opus genetics launches $40m at-the-market equity program by investing.com Investing.com South Africa Tue, 14 Jan 2025 16:13:04 GMT
• mydriasis pipeline 2024: clinical trials assessment, fda approvals, therapies, and key companies involved by delveinsight | viatri... The Globe and Mail Fri, 10 Jan 2025 01:57:24 GMT
• mydriasis pipeline 2024: clinical trials assessment, fda approvals, therapies, and key companies involved by delveinsight | viatri... The Globe and Mail Thu, 09 Jan 2025 08:00:00 GMT
• opus genetics ceo magrath george buys $97,600 in stock Investing.com Mon, 30 Dec 2024 08:00:00 GMT
• opus genetics aligns with fda on phase 3 trial for diabetic retinopathy drug Investing.com Canada Fri, 20 Dec 2024 09:33:53 GMT
• opus genetics aligns with fda on phase 3 trial for diabetic retinopathy drug Investing.com Thu, 19 Dec 2024 13:53:42 GMT
• ird stock touches 52-week low at $0.84 amid market challenges Investing.com Wed, 18 Dec 2024 08:00:00 GMT
• ocuphire pharma sets end-of-phase 2 meeting with fda in q4 to discuss diabetic retinopathy treatment Marketscreener.com Tue, 17 Dec 2024 00:54:37 GMT
• opus genetics, inc. reports earnings results for the fourth quarter and full year ended december 31, 2023 Marketscreener.com Sun, 15 Dec 2024 02:54:47 GMT
• proliferative diabetic retinopathy market forecast: growth drivers and future directions industry overview,... WhaTech Fri, 06 Dec 2024 01:02:05 GMT
• opus genetics, inc. to host virtual kol event on opgx-lca5 as a treatment for lca5-associated inherited retinal disease on decembe... Marketscreener.com Tue, 03 Dec 2024 13:00:00 GMT
• opus genetics president benjamin yerxa acquires $9,834 in stock Investing.com India Tue, 26 Nov 2024 08:00:00 GMT
• opus genetics president benjamin yerxa acquires $9,834 in stock Investing.com Mon, 25 Nov 2024 08:00:00 GMT
• fy2024 eps estimates for opus genetics cut by hc wainwright Defense World Sat, 16 Nov 2024 07:51:38 GMT
• wainwright sets stock target on opus genetics, cites 2025 catalysts Investing.com India Thu, 14 Nov 2024 11:59:20 GMT
• ird stock touches 52-week low at $1.07 amid market challenges Investing.com India Thu, 14 Nov 2024 08:00:00 GMT
• opus genetics, inc. reports earnings results for the second quarter and six months ended june 30, 2024 Marketscreener.com Wed, 13 Nov 2024 14:00:28 GMT
• opus genetics reports $7.5 million net loss in third quarter Vision Monday Wed, 13 Nov 2024 08:00:00 GMT
• wainwright sets stock target on opus genetics, cites 2025 catalysts Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• ird stock touches 52-week low at $1.07 amid market challenges Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• opus genetics announces financial results for third quarter 2024 and provides corporate update GlobeNewswire Tue, 12 Nov 2024 08:00:00 GMT
• The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics PR Newswire Fri, 25 Oct 2024 07:00:00 GMT
• Ocuphire buys Opus Genetics, grows gene therapy pipeline The Pharma Letter Thu, 24 Oct 2024 07:00:00 GMT
• ocuphire pharma announces acquisition of opus genetics VisionMonday.com Thu, 24 Oct 2024 07:00:00 GMT
• north carolina gains public company with merger The Business Journals Thu, 24 Oct 2024 07:00:00 GMT
• ocuphire shares rise after extended us patent for nyxol eye drops secured Marketscreener.com Thu, 24 Oct 2024 03:47:57 GMT
• ocuphire pharma, inc. announces appointments of nirav jhaveri, c.f.a., m.b.a. as chief financial officer Marketscreener.com Thu, 24 Oct 2024 03:00:34 GMT
• ocuphire to transform into gene therapy biotech via opus buyout Fierce Biotech Wed, 23 Oct 2024 09:31:35 GMT
• ocuphire pharma to transform into gene therapy-focused biotech via opus acquisition Fierce Biotech Wed, 23 Oct 2024 09:31:35 GMT
• ocuphire pharma acquires opus genetics in all-stock deal by investing.com Investing.com Australia Wed, 23 Oct 2024 07:59:25 GMT
• Ocuphire Pharma to transform into gene-therapy-focused biotech via Opus acquisition Fierce Biotech Wed, 23 Oct 2024 07:00:00 GMT
• Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders Business Wire Wed, 23 Oct 2024 07:00:00 GMT
• Ocuphire and Opus Genetics merge to develop IRD gene therapy Pharmaceutical Technology Wed, 23 Oct 2024 07:00:00 GMT
• Ocuphire pivots to retinal gene therapies with Opus Genetics buy FirstWord Pharma Wed, 23 Oct 2024 07:00:00 GMT
• ocuphire pharma merges with opus genetics, renamed opus genetics Yahoo Finance Wed, 23 Oct 2024 07:00:00 GMT
• ophthalmic biopharmaceutical ocuphire pharma shifts focus to gene therapy through opus genetics stock deal Benzinga Wed, 23 Oct 2024 07:00:00 GMT
• ocup stock touches 52-week low at $1.14 amid market challenges Investing.com Wed, 23 Oct 2024 07:00:00 GMT
• ocuphire pharma price target lowered to $10 from $18 at canaccord TipRanks Wed, 23 Oct 2024 07:00:00 GMT
• wilson sonsini advises opus genetics on ip matters related to acquisition by ocuphire pharma Wilson Sonsini Wed, 23 Oct 2024 01:00:35 GMT
• Ocuphire Pharma Announces Acquisition of Opus Genetics GlobeNewswire Tue, 22 Oct 2024 07:00:00 GMT
• Ocuphire Pharma acquires Opus Genetics in all-stock transaction, to switch name Nasdaq Tue, 22 Oct 2024 07:00:00 GMT
• Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder Endpoints News Tue, 22 Oct 2024 07:00:00 GMT
• wilson sonsini advises opus genetics on ip matters related to acquisition by ocuphire pharma Wilson Sonsini Tue, 22 Oct 2024 07:00:00 GMT
• ocuphire pharma merges with opus genetics, renamed opus genetics TipRanks Tue, 22 Oct 2024 07:00:00 GMT
• ocuphire pharma and opus genetics announce merger Ophthalmology Times Europe Tue, 22 Oct 2024 07:00:00 GMT
• open angle glaucoma market forecasted to surge in coming years, 2023-2032 analysis by delveinsight | visiox pharma, tearclear, viv... Barchart Fri, 18 Oct 2024 13:02:00 GMT
• presbyopia market on track for major expansion by 2034, according to delveinsight | eyenovia, orasis pharma, ocuphire pharma, nova... The Globe and Mail Wed, 16 Oct 2024 07:00:00 GMT
• night vision disturbances market forecasted to surge in coming openPR Fri, 11 Oct 2024 19:55:00 GMT
• mydriasis market forecasted to surge in coming years, 2024-2034 openPR Thu, 10 Oct 2024 19:52:00 GMT
• results released from ocuphire pharma of mira-2 and mira-3 clinical trials for phentolamine ophthalmic solution 0.75% for pharmaco... Optometry Times Fri, 04 Oct 2024 07:00:00 GMT
• ocuphire reports positive phase 3 results for eye treatment ryzumvi Investing.com Tue, 01 Oct 2024 01:44:10 GMT
• ocuphire pharma releases results from mira-2 and mira-3 clinical trials for phentolamine ophthalmic solution 0.75% for pharmacolog... Ophthalmology Times Mon, 30 Sep 2024 14:03:45 GMT
• ocuphire pharma announces publication of phase 3 results of ryzumvi TipRanks Mon, 30 Sep 2024 13:13:34 GMT
• ocuphire reports positive phase 3 results for eye treatment ryzumvi Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• mydriasis treatment market booming worldwide with leading key openPR Wed, 18 Sep 2024 13:23:08 GMT
• ocuphire pharma, inc. (ocup) reports q2 loss, lags revenue estimates MSN Sat, 07 Sep 2024 10:48:42 GMT
• First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia Healio Fri, 06 Sep 2024 07:00:00 GMT
• ocuphire pharma commences phase 3 trial for presbyopia treatment Investing.com India Fri, 06 Sep 2024 04:57:52 GMT
• update – ocuphire pharma initiates vega-3 phase 3 trial GlobeNewswire Fri, 06 Sep 2024 00:43:00 GMT
• ocuphire pharma inc [ocup] chief scientific & dev. ofc. makes an insider purchase of 3,500 shares worth 6178.0. Knox Daily Thu, 05 Sep 2024 11:51:05 GMT
• update – ocuphire pharma initiates vega-3 phase 3 trial GlobeNewswire Thu, 05 Sep 2024 07:00:00 GMT
• ocuphire pharma doses first patient in phase 3 vega-3 clinical trial Ophthalmology Times Thu, 05 Sep 2024 07:00:00 GMT
• ocuphire pharma initiates vega-3 phase 3 trial evaluating phentolamine ophthalmic solution 0.75% for presbyopia Yahoo Finance Thu, 05 Sep 2024 07:00:00 GMT
• ocuphire pharma commences phase 3 trial for presbyopia treatment by investing.com Investing.com Australia Thu, 05 Sep 2024 07:00:00 GMT
• ocup stock touches 52-week low at $1.15 amid market challenges Investing.com Thu, 05 Sep 2024 02:38:10 GMT
• ocup stock touches 52-week low at $1.15 amid market challenges Investing.com Canada Wed, 04 Sep 2024 07:00:00 GMT
• there is no way ocuphire pharma inc (ocup) can keep these numbers up SETE News Mon, 02 Sep 2024 13:43:36 GMT
• ocuphire pharma inc (ocup) stock: a year of ups and downs US Post News Mon, 02 Sep 2024 07:00:00 GMT
• ocuphire pharma (nasdaq:ocup) stock quotes, forecast and news summary Benzinga Fri, 23 Aug 2024 22:07:00 GMT
• ocuphire pharma inc’s latest rating changes from various analysts Knox Daily Wed, 21 Aug 2024 20:32:48 GMT
• ocup stock earnings: ocuphire pharma misses eps, misses revenue for q2 2024 MSN Wed, 21 Aug 2024 05:49:48 GMT
• analyst forecasts for ocuphire pharma, inc. (nasdaq:ocup) are surging higher simplywall.st Mon, 19 Aug 2024 07:00:00 GMT
• ocuphire pharma announces 2024 second quarter financial results Vision Monday Mon, 19 Aug 2024 07:00:00 GMT
• ocuphire pharma (stu:r3x1) eps (basic) : €-0.50 (ttm as of jun. 2024) GuruFocus.com Sun, 18 Aug 2024 16:41:52 GMT
• ocuphire pharma (stu:r3x1) ev-to-revenue : -0.39 (as of aug. 18, 2024) GuruFocus.com Sun, 18 Aug 2024 15:53:43 GMT
• ocup (ocuphire pharma) 3-year fcf growth rate : 67.10% (as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 23:58:46 GMT
• ocup (ocuphire pharma) debt-to-revenue : 0.00 (as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 21:50:04 GMT
• ocup (ocuphire pharma) 50-day sma : $1.71 (as of aug. 17, 2024) GuruFocus.com Sat, 17 Aug 2024 21:38:04 GMT
• ocup (ocuphire pharma) net income : $-14.11 mil (ttm as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 21:37:22 GMT
• canaccord genuity group reaffirms buy rating for ocuphire pharma (nasdaq:ocup) Defense World Sat, 17 Aug 2024 07:00:00 GMT
• ocuphire pharma (fra:r3x1) pe ratio (ttm) : at loss (as of aug. 18, 2024) GuruFocus.com Fri, 16 Aug 2024 22:42:51 GMT
• was anything negative for ocuphire pharma inc (ocup) stock last session? US Post News Fri, 16 Aug 2024 13:28:17 GMT
• ocuphire pharma, inc. (nasdaq:ocup) forecasted to post q3 2024 earnings of ($0.30) per share Defense World Fri, 16 Aug 2024 12:30:43 GMT
• ocuphire pharma, inc. (nasdaq:ocup) reported earnings last week and analysts are already upgrading their estimates Yahoo Finance Fri, 16 Aug 2024 07:00:00 GMT
• ocuphire pharma inc’s latest rating changes from various analysts Knox Daily Wed, 14 Aug 2024 21:01:49 GMT
• ocuphire pharma inc (ocup) stock: a year of declines and increases The InvestChronicle Wed, 14 Aug 2024 14:33:09 GMT
• financial health check: examining ocuphire pharma inc (ocup)’s key ratios The Dwinnex Wed, 14 Aug 2024 11:20:56 GMT
• ocuphire shares price target cut, buy rating held on fda approval milestone Investing.com Wed, 14 Aug 2024 07:00:00 GMT
• ocuphire pharma price target lowered to $18 from $20 at h.c. wainwright TipRanks Wed, 14 Aug 2024 07:00:00 GMT
• ocuphire pharma, inc. (ocup) reports q2 loss, lags revenue estimates Yahoo Finance UK Tue, 13 Aug 2024 13:10:04 GMT
• Ocuphire Pharma Announces Financial Results for Second Quarter 2024 and Provides Corporate Update GlobeNewswire Tue, 13 Aug 2024 07:00:00 GMT
• ocup stock touches 52-week low at $1.47 amid market challenges Investing.com Tue, 13 Aug 2024 07:00:00 GMT
• ocuphire pharma, inc. reports earnings results for the second quarter and six months ended june 30, 2024 Marketscreener.com Tue, 13 Aug 2024 07:00:00 GMT
• ocup stock earnings: ocuphire pharma misses eps, misses revenue for q2 2024 InvestorPlace Tue, 13 Aug 2024 07:00:00 GMT
• virtu financial llc takes $36,000 position in ocuphire pharma, inc. (nasdaq:ocup) Defense World Fri, 09 Aug 2024 09:57:05 GMT
• ocuphire pharma to present at two investor conferences in august GlobeNewswire Thu, 08 Aug 2024 07:00:00 GMT
• here's why we're not at all concerned with ocuphire pharma's (nasdaq:ocup) cash burn situation Yahoo Finance Thu, 01 Aug 2024 07:00:00 GMT
• short interest in ocuphire pharma, inc. (nasdaq:ocup) decreases by 15.8% MarketBeat Sun, 28 Jul 2024 07:00:00 GMT
• ocuphire pharma, inc. (nasdaq:ocup) sees significant decline in short interest Defense World Sun, 28 Jul 2024 07:00:00 GMT
• comparing vectura group (otcmkts:vegpf) and ocuphire pharma (nasdaq:ocup) Defense World Wed, 24 Jul 2024 07:40:37 GMT
• APX3330 oral treatment for diabetic retinopathy shows encouraging phase 2 data Healio Wed, 24 Jul 2024 07:00:00 GMT
• investors still aren't entirely convinced by ocuphire pharma, inc.'s (nasdaq:ocup) revenues despite 30% price jump Simply Wall St Wed, 24 Jul 2024 07:00:00 GMT
• empowered funds llc purchases shares of 36,605 ocuphire pharma, inc. (nasdaq:ocup) Defense World Mon, 22 Jul 2024 07:00:00 GMT
• ocup (ocuphire pharma) float percentage of total shares out GuruFocus.com Wed, 17 Jul 2024 18:21:10 GMT
• understanding the risks of investing in ocuphire pharma inc (ocup) Knox Daily Wed, 17 Jul 2024 11:08:23 GMT
• companies like ocuphire pharma (nasdaq:ocup) are in a position to invest in growth Simply Wall St Fri, 12 Jul 2024 07:00:00 GMT
• presbyopia pipeline review, 2024 updates | latest fda, ema, and pmda approvals|작성자 delveinsight-blogs Coin Plus（コインプラス） Thu, 11 Jul 2024 04:56:12 GMT
• ocuphire pharma spotlights diabetic retinopathy treatment Investing.com Wed, 10 Jul 2024 19:00:18 GMT
• compass digital acquisition corp. sets new date for shareholder meeting by investing.com Investing.com India Wed, 10 Jul 2024 18:56:15 GMT
• ocuphire pharma to highlight apx3330 at arvo sig panel, asrs meeting TipRanks Wed, 10 Jul 2024 12:22:30 GMT
• Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July GlobeNewswire Wed, 10 Jul 2024 07:00:00 GMT
• kintara therapeutics restructures share designations by investing.com Investing.com India Wed, 10 Jul 2024 07:00:00 GMT
• presbyopia pipeline review, 2024 updates | latest fda, ema, and pmda approvals - coin plus（コインプラス） Coin Plus（コインプラス） Thu, 04 Jul 2024 07:28:51 GMT
• ocuphire pharma | biotechnology | the pharmaletter The Pharma Letter Mon, 01 Jul 2024 01:13:06 GMT
• ocuphire pharma's (nasdaq:ocup) investors will be pleased with their 21% return over the last year Yahoo New Zealand News Sun, 30 Jun 2024 01:20:00 GMT
• ocuphire completes enrollment of over 100 subjects in 24-week zeta-1 phase 2b trial of oral apx3330 for the ... Barchart Fri, 21 Jun 2024 03:44:20 GMT
• understanding the risks of investing in ocuphire pharma inc (ocup) Knox Daily Wed, 19 Jun 2024 17:11:56 GMT
• video: oral treatment shows promise in slowing diabetic retinopathy progression Healio Wed, 19 Jun 2024 07:00:00 GMT
• these 3 clinical-stage biotech stocks can offer exponential gains Head Topics Fri, 14 Jun 2024 07:00:00 GMT
• ocuphire pharma announces presentations on development of apx3330 - tipranks.com TipRanks Fri, 07 Jun 2024 23:54:55 GMT
• ocuphire pharma to present apx3330 clinical updates by investing.com Investing.com Nigeria Fri, 07 Jun 2024 01:59:18 GMT
• diabetic macular edema pipeline and clinical trials assessment 2024: fda approvals, therapies and key ... openPR Thu, 06 Jun 2024 20:15:00 GMT
• ocuphire pharma announces presentations on the development of apx3330 for diabetic retinopathy at retina meetings in june Yahoo Finance Thu, 06 Jun 2024 07:00:00 GMT
• presbyopia market to register incremental growth during the forecast period | abbvie, eyenovia, orasis pharmaceuticals, novartis, ... Barchart Thu, 06 Jun 2024 07:00:00 GMT
• barclays keeps overweight rating on spring works shares by investing.com Investing.com Thu, 06 Jun 2024 07:00:00 GMT
• ocuphire pharma, inc. (ocup) just flashed golden cross signal: do you buy? Yahoo New Zealand News Sat, 01 Jun 2024 12:26:55 GMT
• analyzing ratios: ocuphire pharma inc (ocup)'s financial story unveiled – dwinnex The Dwinnex Thu, 30 May 2024 15:27:52 GMT
• ocuphire pharma, inc. (nasdaq:ocup) about to shift from loss to profit Yahoo News UK Tue, 28 May 2024 20:08:23 GMT
• victory capital management inc. buys shares of 46916 ocuphire pharma, inc. (nasdaq:ocup) Defense World Tue, 28 May 2024 08:23:10 GMT
• ocuphire pharma, inc. (ocup) just flashed golden cross signal: do you buy? Yahoo New Zealand News Mon, 27 May 2024 03:47:00 GMT
• ocuphire rallies after h.c. wainwright initiates stock with a buy Yahoo Movies UK Sun, 26 May 2024 09:12:00 GMT
• h.c. wainwright cuts cartesian therapeutics shares target on trial reassessment by investing.com Investing.com India Sat, 25 May 2024 07:00:00 GMT
• ocuphire pharma exec acquires $6.2k in company stock by investing.com Investing.com India Sat, 25 May 2024 07:00:00 GMT
• ra capital management buys $49.95m of eliem therapeutics stock by investing.com Investing.com India Wed, 22 May 2024 07:00:00 GMT
• ocuphire pharma ceo acquires $8.8k in company stock by investing.com Investing.com India Wed, 22 May 2024 07:00:00 GMT
• duos technologies and 2 other stocks under $3 insiders are buying - duos technologies group (nasdaq:duot) Benzinga Wed, 22 May 2024 07:00:00 GMT
• ocuphire pharma ceo acquires $8.8k in company stock by investing.com Investing.com Tue, 21 May 2024 07:00:00 GMT
• diabetic retinopathy pipeline analysis, 2024 updates | latest fda, ema, and pmda approvals openPR Mon, 20 May 2024 20:07:00 GMT
• ocuphire pharma, inc. (ocup) gains as market dips: what you should know Yahoo New Zealand News Mon, 20 May 2024 01:20:43 GMT
• ocuphire pharma, inc. (ocup) gains as market dips: what you should know Yahoo New Zealand News Sat, 18 May 2024 16:53:12 GMT
• the market lifts ocuphire pharma, inc. (nasdaq:ocup) shares 42% but it can do more Yahoo Movies Canada Sat, 18 May 2024 11:31:16 GMT
• q2 2024 eps estimates for ocuphire pharma, inc. decreased by hc wainwright (nasdaq:ocup) Defense World Thu, 16 May 2024 11:29:23 GMT
• ocuphire pharma (nasdaq:ocup) raised to strong-buy at canaccord genuity group Defense World Thu, 16 May 2024 07:00:00 GMT
• ocuphire pharma, inc. (nasdaq:ocup) to post fy2028 earnings of $1.74 per share, hc wainwright forecasts Defense World Thu, 16 May 2024 07:00:00 GMT
• canaccord genuity group lowers ocuphire pharma (nasdaq:ocup) price target to $18.00 Defense World Wed, 15 May 2024 14:01:53 GMT
• ocuphire pharma (nasdaq:ocup) rating reiterated by hc wainwright Defense World Wed, 15 May 2024 07:40:26 GMT
• myopia and presbyopia eye drops market set to high growth, emerging trends, business opportunities and forecast ... openPR Mon, 13 May 2024 06:45:00 GMT
• ocuphire pharma first quarter 2024 earnings: misses expectations Yahoo Finance Sun, 12 May 2024 07:00:00 GMT
• ocuphire pharma gambles on cash-pay strategy for ryzumvi: is it a path to profit or a financial pitfall? TipRanks Sun, 12 May 2024 06:03:09 GMT
• ocuphire pharma gambles on cash-pay strategy for ryzumvi: is it a path to profit or a financial pitfall? TipRanks Sat, 11 May 2024 07:00:00 GMT
• ocuphire pharma announces financial results for first quarter 2024 and provides corporate update GlobeNewswire Sat, 11 May 2024 04:26:40 GMT
• ocuphire pharma earnings missed by $0.18, revenue fell short of estimates Investing.com India Fri, 10 May 2024 19:19:11 GMT
• ocuphire pharma reports q1 eps (29c), consensus (13c) - tipranks.com TipRanks Fri, 10 May 2024 12:00:00 GMT
• ocuphire pharma, inc. (ocup) gains as market dips: what you should know Yahoo New Zealand News Fri, 10 May 2024 11:45:43 GMT
• ocuphire pharma, inc. (nasdaq:ocup) stock holdings lifted by kestra private wealth services llc Defense World Fri, 10 May 2024 09:13:09 GMT
• ocuphire pharma announces financial results for first quarter 2024 and provides corporate update GlobeNewswire Fri, 10 May 2024 07:00:00 GMT
• ocuphire pharma shares updates in upcoming investor meetings TipRanks Fri, 10 May 2024 07:00:00 GMT
• ocuphire pharma announces presentation on apx3330 at arvo 2024 - tipranks.com TipRanks Tue, 07 May 2024 12:58:24 GMT
• ocuphire pharma (stu:r3x1) preferred stock : €0.00 mil (as of dec. 2023) GuruFocus.com Tue, 07 May 2024 02:18:51 GMT
• Ocuphire Pharma Announces Presentation on APX3330 at the ARVO 2024 Annual Meeting GlobeNewswire Mon, 06 May 2024 07:00:00 GMT
• ocuphire provides corporate update and reiterates previous guidance on clinical programs IT Business Net Sun, 05 May 2024 13:29:15 GMT
• buying buzz: ocuphire pharma inc [ocup] chief financial officer jhaveri nirav s. purchases 10000 shares of the ... Knox Daily Sat, 04 May 2024 00:24:31 GMT
• ocuphire pharma, inc. (ocup) is a great momentum stock: should you buy? Yahoo Movies Canada Fri, 03 May 2024 19:30:00 GMT
• ocuphire pharma inc (ocup) stock: navigating a year of volatility – invest chronicle The InvestChronicle Fri, 03 May 2024 13:10:33 GMT
• ocuphire pharma to present at the aegis virtual conference GlobeNewswire Fri, 03 May 2024 07:00:00 GMT
• ocuphire pharma announces presentation on apx3330 at the GlobeNewswire Thu, 02 May 2024 07:00:00 GMT
• slammed 26% ocuphire pharma, inc. (nasdaq:ocup) screens well here but there might be a catch Simply Wall St Thu, 02 May 2024 07:00:00 GMT
• ocuphire pharma, inc. (ocup) is a great momentum stock: should you buy? Yahoo Lifestyle Australia Sat, 27 Apr 2024 15:54:10 GMT
• does ocuphire pharma, inc. (ocup) have the potential to rally 323.89% as wall street analysts expect? Yahoo Canada Shine On Thu, 25 Apr 2024 06:02:50 GMT
• ocuphire pharma, inc. (ocup) is a great momentum stock: should you buy? Yahoo Movies UK Tue, 23 Apr 2024 14:38:42 GMT
• ocuphire pharma announces apx3330 presentation at arvo 2024 annual meeting GlobeNewswire Mon, 22 Apr 2024 07:00:00 GMT
• First patient enrolled LYNX-2 study of eye drop for reduced visual acuity in low light Healio Wed, 17 Apr 2024 07:00:00 GMT
• ocuphire pharma incentivizes director pepose with stocks and options - tipranks.com TipRanks Wed, 17 Apr 2024 07:00:00 GMT
• glaucoma market to observe impressive growth during the forecast period (2024-2034), evaluates delveinsight openPR Fri, 12 Apr 2024 16:12:00 GMT
• first patient enrolled in lynx-2 phase 3 study evaluating GlobeNewswire Thu, 11 Apr 2024 07:00:00 GMT
• lenz therapeutics' eye drop helps improve vision in late-stage study Reuters Wed, 03 Apr 2024 07:00:00 GMT
• technical analysis of ocuphire pharma inc (ocup) stock chart patterns – us post news US Post News Wed, 03 Apr 2024 07:00:00 GMT
• ocuphire pharma inc's latest rating changes from various analysts – knox daily Knox Daily Tue, 02 Apr 2024 16:25:56 GMT
• is masimo (masi) outperforming other medical stocks this year? Yahoo Movies UK Mon, 01 Apr 2024 19:47:23 GMT
• Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ GlobeNewswire Mon, 01 Apr 2024 07:00:00 GMT
• ocuphire and viatris launch eye disorder treatment ryzumvi by investing.com Investing.com South Africa Mon, 01 Apr 2024 07:00:00 GMT
• cathie wood's ark etf focuses on pagerduty, 10x genomics stock by investing.com Investing.com Mon, 01 Apr 2024 07:00:00 GMT
• viatris launches ryzumvi in usa | the pharmaletter The Pharma Letter Mon, 01 Apr 2024 07:00:00 GMT
• ocuphire pharma inc [ocup] stock trading around $2.01 per share: what's next? – the dbt news The DBT News Fri, 29 Mar 2024 20:18:18 GMT
• can you still get a good price for ocuphire pharma inc (ocup) shares at this point? – us post news US Post News Fri, 29 Mar 2024 17:50:13 GMT
Ocuphire Pharma Inc(NASDAQ:OCUP) 
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of various eye disorders. The company is headquartered in Farmington Hills, Michigan.
Website: https://www.ocuphire.com/
Founded: 2018
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS